Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Epidemics
|
March 18, 2019
Efficient vaccination strategies for epidemic control using network information
Yingrui Yang, Ashley McKhann, Sixing Chen, et al.
AIDS Research and Human Retroviruses
|
June 11, 2019
Immune Correlates of Herpes Zoster in People Living with HIV on Effective Antiretroviral Therapy
Adriana Tovar Salazar, Ashley McKhann, Huichao Chen, et al.
AIDS (London, England)
|
June 4, 2019
Soluble suppression of tumorigenicity 2 levels are not predictive of non-AIDS events during antiretroviral therapy-mediated viral suppression
Alexis Kay, Carlee Moser, Ashley McKhann, et al.
AIDS (London, England)
|
August 9, 2021
Plasma galectin-9 as a predictor of adverse non-AIDS events in persons with chronic HIV during suppressive antiretroviral therapy
Thomas A Premeaux, Carlee B Moser, Ashley McKhann, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
October 25, 2021
Brief Report: No Differences Between Lopinavir/Ritonavir and Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy on Clearance of Plasmodium falciparum Subclinical Parasitemia in Adults Living With HIV Starting Treatment (A5297)
Douglas Shaffer, Johnstone Kumwenda, Huichao Chen, et al.
Open Forum Infectious Diseases
|
February 11, 2022
Monitoring Circulating Immune Checkpoint Proteins as Predictors of Non-AIDS Morbid Events in People With HIV Initiating Antiretroviral Therapy
Thomas A Premeaux, Carlee B Moser, Ashley McKhann, et al.
AIDS (London, England)
|
April 10, 2020
Presence of asymptomatic cytomegalovirus and Epstein--Barr virus DNA in blood of persons with HIV starting antiretroviral therapy is associated with non-AIDS clinical events
Sara Gianella, Carlee Moser, Andrej Vitomirov, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
December 13, 2025
The Effect of Low Dose Methotrexate on Arterial Inflammation in Persons Living with Human Immunodeficiency Virus. A double-blind randomized placebo-controlled pilot trial
Ahmed Tawakol, Heather Ribaudo, Ashley McKhann, et al.
Plos One
|
February 13, 2023
Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)-report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerability and efficacy randomised, amphotericin B-controlled trial of the AIDS Clinical Trials Group
Umesh G Lalloo, Lauren Komarow, Judith A Aberg, et al.
Open Forum Infectious Diseases
|
January 5, 2026
Monocyte Activation in People With HIV and Tuberculosis Coinfection and Effect of Tuberculosis Preventive Therapy: An Analysis of the ACTG A5279/BRIEF TB Trial
Moises A Huaman, Manuel G Feria, Michelle A Kendall, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Epidemics
|
March 18, 2019
Efficient vaccination strategies for epidemic control using network information
Yingrui Yang, Ashley McKhann, Sixing Chen, et al.
AIDS Research and Human Retroviruses
|
June 11, 2019
Immune Correlates of Herpes Zoster in People Living with HIV on Effective Antiretroviral Therapy
Adriana Tovar Salazar, Ashley McKhann, Huichao Chen, et al.
AIDS (London, England)
|
June 4, 2019
Soluble suppression of tumorigenicity 2 levels are not predictive of non-AIDS events during antiretroviral therapy-mediated viral suppression
Alexis Kay, Carlee Moser, Ashley McKhann, et al.
AIDS (London, England)
|
August 9, 2021
Plasma galectin-9 as a predictor of adverse non-AIDS events in persons with chronic HIV during suppressive antiretroviral therapy
Thomas A Premeaux, Carlee B Moser, Ashley McKhann, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
October 25, 2021
Brief Report: No Differences Between Lopinavir/Ritonavir and Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy on Clearance of Plasmodium falciparum Subclinical Parasitemia in Adults Living With HIV Starting Treatment (A5297)
Douglas Shaffer, Johnstone Kumwenda, Huichao Chen, et al.
Open Forum Infectious Diseases
|
February 11, 2022
Monitoring Circulating Immune Checkpoint Proteins as Predictors of Non-AIDS Morbid Events in People With HIV Initiating Antiretroviral Therapy
Thomas A Premeaux, Carlee B Moser, Ashley McKhann, et al.
AIDS (London, England)
|
April 10, 2020
Presence of asymptomatic cytomegalovirus and Epstein--Barr virus DNA in blood of persons with HIV starting antiretroviral therapy is associated with non-AIDS clinical events
Sara Gianella, Carlee Moser, Andrej Vitomirov, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
December 13, 2025
The Effect of Low Dose Methotrexate on Arterial Inflammation in Persons Living with Human Immunodeficiency Virus. A double-blind randomized placebo-controlled pilot trial
Ahmed Tawakol, Heather Ribaudo, Ashley McKhann, et al.
Plos One
|
February 13, 2023
Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)-report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerability and efficacy randomised, amphotericin B-controlled trial of the AIDS Clinical Trials Group
Umesh G Lalloo, Lauren Komarow, Judith A Aberg, et al.
Open Forum Infectious Diseases
|
January 5, 2026
Monocyte Activation in People With HIV and Tuberculosis Coinfection and Effect of Tuberculosis Preventive Therapy: An Analysis of the ACTG A5279/BRIEF TB Trial
Moises A Huaman, Manuel G Feria, Michelle A Kendall, et al.
Page
of 2